Author Profile

Brian O'Flynn, PhD

Brian O'Flynn, PhD

Scientific Writer

Brian O’Flynn, PhD, is a Scientific Writer in the Strategic Communications, Education and Outreach Department at St. Jude.

Stories by Brian O'Flynn

St. Jude On

The turbulent chemistry behind smarter, safer therapeutics

Brian O'Flynn, PhD

Explore the ingenuity behind therapeutic optimization

Clinical

Reducing the risk of posterior fossa syndrome: Questions for Paul Klimo, MD

Paul Klimo, MD and Brian O'Flynn, PhD

Neurosurgeon Paul Klimo, MD, explains posterior fossa syndrome, and how surgeons can work to reduce its risk.

Research

Integrated sequencing approach provides gold standard pediatric AML diagnosis

Brian O'Flynn, PhD

See how combining sequencing approaches provides a ‘one-stop shop’ for diagnosing AML.

Research

Genomic Medicine Initiative (GEMINI) targets unmet needs in rare disease treatment

Jake Hopkins, MBA and Brian O'Flynn, PhD

Learn how GEMINI addresses the challenges of rare genetic diseases

St. Jude On

Conversations with survivors of cancer guide therapeutic interventions

Brian O'Flynn, PhD

See how St. Jude gives power to the voices of long-term survivors of childhood cancer

Clinical

Gene therapy comes of age to staunch hemophilia B

Brian O'Flynn, PhD

See the long-term impact a hemophilia B gene therapy trial had on one of its participants

Research

A continuum of innovation brings patients a new treatment for Ewing sarcoma

Brian O'Flynn, PhD

See how a treatment combo propels Ewing sarcoma radiation therapy to new heights

St. Jude On

Biomolecular organization holds tantalizing clues for neurological disease treatment

Brian O'Flynn, PhD

 See how microscopic “bubbles” set the stage for neurological breakthroughs

Research

Laying the foundation for neuronal development

Brian O'Flynn, PhD

See how blocking one kinase resulted in premature neuron growth

Research

Protein turnover information provides new insights and may guide researchers to more accurate Alzheimer's disease models

Brian O'Flynn, PhD

See how a collaborative effort in proteomics produced a comprehensive turnover atlas and sparked discovery in Alzheimer’s disease research.